UAB, Southern Research make headway on diabetes drug candidate
The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that may offer a major advancement for diabetes treatment.
The experimental drug, which was tested on cell cultures for both Type 1 and Type 2 diabetes, significantly improved four detrimental characteristics of diabetes, including high blood sugar, elevation in the hormone glucagon that counteracts the effects of insulin, promotes glucose production and increases blood glucose; excessive production…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tyler Patchen Source Type: news
More News: Biotechnology | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Health Management | Hormones | Insulin | Sugar